Latest Stanford V Stories
A lower dose of radiation used to reduce side effects is not as effective as the regular dose when given with the standard chemotherapy in the treatment of Hodgkin's lymphoma patients with early, intermediate-stage disease.
U.S. medical scientists say they have developed a new chemotherapy regimen for pediatric Hodgkin's lymphoma patients. Dr.
- totally perplexed and mixed up.